Friday 6 November 2026
Export MYO’s income statement to Excel — free account
Myomo, Inc.
MYO Healthcare Medical Devices
Myomo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.9 million, up 25.7% from fiscal 2024.
- Revenue
- +21.3%
- EPS
- +18.2%
- Free cash flow
- +80.0%
- Total debt
- +199.5%
Quarter to June 2026, against a year earlier
1.22
0.03
+2.52%
Follow MYO
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
1 | 2 | 2 | 4 |
+8 more TTM periods Free account |
| (123.76%) | (98.53%) | (86.24%) | (100.51%) | ||
| (39.20%) | (38.95%) | (38.51%) | (47.71%) | ||
ROIC |
(167.90%) | (207.35%) | (212.70%) | (122.21%) | |
Return on Tangible Assets |
(91.23%) | (81.65%) | (72.69%) | (68.84%) | |
Average Days of Receivables |
41.73 | 42.73 | 36.53 | 46.39 | |
Free Cash Flow per Share |
(0.21) | (0.41) | (0.43) | (0.33) | |
Free Cash Flow |
(9.09) | (17.19) | (17.84) | (13.85) | |
Capital Expenditures |
(1.98) | (3.16) | (3.33) | (3.84) | |
| Other line items | |||||
Cash ROIC |
(29.07%) | (48.25%) | (43.50%) | (44.41%) | |
Accounts Receivable Turnover |
7.21 | 8.69 | 10.33 | 9.23 | |
Accounts Payable Turnover |
1.73 | 1.61 | 1.89 | 2.12 | |
Inventory Turnover |
3.75 | 4.06 | 4.46 | 3.96 | |
Average Days of Payables |
200.36 | 182.66 | 151.30 | 174.80 | |
Days of Inventory on Hand |
84.49 | 92.32 | 81.19 | 95.56 | |
Tax Rate |
0.03 | 0.04 | 0.03 | 0.04 | |
Research and Development Expense of Revenue |
15.02% | 16.45% | 16.97% | 16.52% | |
Selling, General and Administrative Expense of Revenue |
80.39% | 83.58% | 83.92% | 78.56% | |
Share Based Compensation of Revenue |
6.45% | 5.20% | 5.09% | 4.42% | |
Interest Coverage |
— | (26.57) | — | — | |
Operating CF/Net income |
0.49 | 0.93 | 0.93 | 0.83 | |
Depreciation/Fixed assets |
1.53 | 1.20 | 1.11 | 0.51 | |
Capex/Depreciation |
(0.65) | (1.18) | (1.36) | (2.04) | |
Revenue per Share |
1.01 | 0.97 | 0.98 | 0.99 | |
Operating CF per Share |
(0.17) | (0.33) | (0.35) | (0.24) | |
Capex per Share |
(0.05) | (0.07) | (0.08) | (0.09) | |
Capex to Sales |
0.05 | 0.08 | 0.08 | 0.09 |
Columns are period end dates · fundamentals updated 26 Oct 2026